1. Killing of Cryptosporidium sporozoites by Lactoferrin
- Author
-
Griselle Martinez-Traverso, Theresa J. Ochoa, Hayley Sparks, Alejandro Castellanos-Gonzalez, A. Clinton White, and Jose Luis Paredes
- Subjects
0301 basic medicine ,animal diseases ,030231 tropical medicine ,Intestinal parasite ,Breast milk ,medicine.disease_cause ,Oocysts/drug effects ,Microbiology ,Lactoferrin/chemistry/pharmacology ,03 medical and health sciences ,fluids and secretions ,0302 clinical medicine ,Virology ,parasitic diseases ,medicine ,Humans ,Parasite hosting ,Cryptosporidium/drug effects ,Sporozoites/drug effects ,biology ,Lactoferrin ,Milk, Human/chemistry ,food and beverages ,Cryptosporidium ,biology.organism_classification ,Antimicrobial ,Diarrhea ,030104 developmental biology ,Infectious Diseases ,Cryptosporidium parvum ,biology.protein ,Parasitology ,medicine.symptom ,purl.org/pe-repo/ocde/ford#3.03.06 [https] - Abstract
Intestinal infection caused by Cryptosporidium is a major contributor to diarrhea morbidity and mortality in young children around the world. Current treatments for children suffering from cryptosporidiosis are suboptimal. Lactoferrin is a glycoprotein found in breast milk. It has showed bacteriostatic and antimicrobial activity in the intestine. However, the effects of lactoferrin on the intestinal parasite Cryptosporidium have not been reported. In this study, we investigated the anticryptosporidial activity of human lactoferrin on different stages of Cryptosporidium. Physiologic concentrations of lactoferrin killed Cryptosporidium parvum sporozoites, but had no significant effect on oocysts viability or parasite intracellular development. Since sporozoites are essential for the infection process, our data reinforce the importance of breastfeeding and point to the potential of lactoferrin as a novel therapeutic agent for cryptosporidiosis.
- Published
- 2017
- Full Text
- View/download PDF